Palantir’s £330 Million NHS Contract Under Scrutiny as Ministers Seek Break Clause

Ministers in the Department of Health and Social Care are actively seeking legal advice on whether they can activate a break clause in the £330 million contract signed with Palantir for the delivery of the NHS Federated Data Platform — a contract that has become a focus of public concern about the role of the US data analytics and intelligence company in the administration of England’s national health service.

The Federated Data Platform is designed to integrate data across NHS trusts and integrated care systems, enabling better coordination of care and more efficient use of health resources. Palantir, which has significant contracts with US defence and intelligence agencies, secured the NHS England contract in 2023 following a competitive procurement process. The deal has attracted sustained opposition from a coalition of privacy advocates, clinicians and civil society organisations who argue that the company’s intelligence community connections create unacceptable risks around data sovereignty and patient privacy.

Louis Mosley, executive vice-chair of Palantir in the UK, responded to reports of ministerial interest in a break clause by urging the government not to give in to what he characterised as “ideologically motivated campaigners.” The claim was swiftly rejected by Chi Onwurah, Labour MP and chair of the House of Commons science, innovation and technology select committee, who said it was entirely appropriate for ministers to explore all contractual options.

NHS Confederation analysis noted that the potential disruption costs of exiting the Palantir contract and replacing the platform with an alternative solution would be substantial, and that any decision needed to weigh the legitimate concerns about the company against the practical consequences of an abrupt transition for NHS operations.